CLDF Title
Home | Contact Us | Bookmark
MASH HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
Embassy of Education
Webcasts Abstract Library LiverQ Academy National Conference Regional Conferences
 
Back  
 
Reuters Health Information (2007-03-30): Neurotrophin receptor regulates liver repair

Science

Neurotrophin receptor regulates liver repair

Last Updated: 2007-03-30 11:12:48 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Neurotrophin receptor p75NTR, a member of the tumor necrosis factor receptor family, plays a key role in guiding the hepatic stellate cell (HSCs) differentiation that occurs during repair of fibrotic and cirrhotic liver injury, new research shows.

Following liver injury, HSCs differentiate into extracellular matrix- and growth factor-producing cells, which promote the hepatocyte proliferation needed for liver regeneration, according to the report in the March 30th issue of Science. However, the regulation of HSC differentiation was unclear.

Using various techniques, Dr. Katerina Akassoglou and colleagues, from the University of California in San Diego, and show that liver disease is worsened and hepatocyte proliferation is impaired in the absence of p75NTR.

Further analysis showed that HSCs lacking p75NTR were unable to differentiate into myofibroblasts and support hepatocyte proliferation, the report indicates. p75NTR signaling appeared to be mediated through the small guanosine triphosphatase Rho.

"Our results identify signaling from p75NTR to Rho as a mechanism for the regulation of HSC differentiation to regeneration-promoting cells that support hepatocyte proliferation in the diseased liver," the investigators conclude.

Science 2007;315:1853-1856.

 
 
 
 

Subscribe

Be the first to know about our latest upcoming programs and events!

CLDF

Follow us

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2025 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.